Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Hydrogel Biodegradable Ureteral Stent

Project description

New biodegradable ureteral treatment

Ureteral disorders present significant challenges, often requiring stent placement, which can lead to complications and necessitate painful removal procedures. Over 80 % of stent-related issues stem from bacterial adhesion and encrustation, placing a burden on patients and healthcare systems alike. In this context, the EIC-funded HYDRUSTENT project aims to revolutionise treatment with a biodegradable, hydrogel-based stent. Designed for flexibility and lubrication, Hydrustent minimises bacterial adhesion and encrustation while degrading harmlessly in urine within 7 to 10 days, eliminating the need for a second removal procedure. This innovation could enhance patient outcomes and save healthcare systems billions of euro with the potential to reach the EU market in 2024 and generate profits within five years.

Objective

Hydrumedical S.A. (HYD) team is composed by a urologist and biomaterials scientists that will revolutionise the treatment of ureteral disorders. Hydrustent is a biodegradable, hydrogel-based, soft, lubricated, and flexible stent. These properties prevent bacterial adhesion (>80% of the stent-related complications) and encrustation development. Nowadays, the application of stents requires a 2nd removal procedure, a burden for patients and healthcare systems. Hydrustent is homogeneously degraded by the urine flow within 7-10 days, eliminating the need of further interventions for its removal. Hydrustent will bring huge health benefits for patients and reduce up to 60% of treatment costs (4.3B€ savings for the health system in EU+US). Validated by the urology community, with a global Ureteral Stents Market raising (~604M€ by 2030), if Hydrustent project is successfully implemented, we intend to reach the EU market in 2024 with profits amounting to 25M€, 5 years after product launch.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-ACCELERATOR-01

See all projects funded under this call

Coordinator

HYDRUMEDICAL SA
Net EU contribution
€ 1 522 762,00
Address
AVEPARK - PARQUE DE CIENCIA E TECNOLOGIA ZONA INDUSTRIAL DA GANDRA
4805-017 GUIMARAES
Portugal
SME
Yes
Region
Continente Norte Ave
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 2 225 375,00